BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2018
View Archived Issues
Rhythm acquires rights to Takeda GOAT inhibitor for Prader-Willi syndrome
Read More
Relationship between PACE4 expression and prognosis differs in colorectal cancer
Read More
PRAME found highly expressed in salivary gland cancer
Read More
FDA grants BLA priority review for moxetumomab pasudotox in hairy cell leukemia
Read More
FDA grants fast track designation for TAR-200 in muscle invasive bladder cancer
Read More
Retrophin initiates pivotal phase III DUPLEX study of sparsentan
Read More
Novartis patents new TLR7/8/9 antagonists
Read More
MedImmune divulges novel anti-VEGF-A antibodies for cancer
Read More
Novel secretomes disclosed by researchers from Korea
Read More
Eli Lilly discovers HAVcr-2-targeting antibodies
Read More
Phase I trial of KA-34 is currently recruiting participants
Read More
FDA grants orphan drug designation for BPN-14770 as treatment of fragile X syndrome
Read More
PRDM15-targeting ASOs presented by A*STAR
Read More
Topline results from phase II study of fostamatinib in IgA nephropathy
Read More
European Commission grants orphan drug designation to Altemia for sickle cell disease
Read More
Patient recruitment ongoing in phase I/II trial of ST-400
Read More
EMA validates MAA for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer
Read More
GenSight reports topline results from REVERSE trial of GS-010 in LHON
Read More
Personal Genome Diagnostics, Five Prime Therapeutics to develop bemarituzumab companion diagnostic
Read More
SpinalCyte reports data from phase I/II trial of CybroCell
Read More
ThromboGenics reports phase I/II topline data on THR-317 for DME
Read More
Eisai submits sNDA for pediatric use of Fycompa
Read More
Pfizer and Allogene enter asset contribution agreement for Pfizer's CAR T portfolio
Read More
SOX-9 unveiled as potential prognostic marker in lymphoma
Read More
Sellas reports interim phase IIb data on Herceptin + NeuVax in breast cancer
Read More
Nkx-6.1 identified as diagnostic marker of lung and pancreatic NETs
Read More